Refractory RA Yields to Rituximab (CME/CE)

(MedPage Today) -- All patient-reported outcomes showed improvements at 1 year
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Geriatrics | Rituxan